Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index rising 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.3%.
The iShares Biotechnology ETF (IBB) increased 1.1%.
In corporate news, Cogent Biosciences (COGT) shares climbed 3.2% after it said Thursday the US Food and Drug Administration has accepted its new drug application for bezuclastinib plus sunitinib to treat patients with gastrointestinal stromal tumors who have been treated with imatinib previously.